Human cytomegalovirus (HCMV) infection is known to modulate host gene expression and has been linked to the pathogenesis of vasculopathies; however, relevant pathomechanisms are still unclear. It was shown that HCMV infection leads to upregulation of vascular endothelial growth factor (VEGF) expression in human foreskin fibroblasts and coronary artery smooth muscle cells (SMC). Activation of VEGF transcription by HCMV infection was confirmed by transient-expression experiments, which revealed that a short promoter fragment, pLuc135 (−85 to +50), is sufficient for activation. Site-directed mutagenesis of Sp1-recognition sites within this fragment abolished the upregulation of transcription. Functional VEGF protein is released into the culture supernatant of infected SMC. Incubation of endothelial cells with supernatants from HCMV-infected SMC cultures induced upregulation of VEGF receptor-2 expression on endothelial cells, as well as a significant upregulation of DNA synthesis, implicating cell proliferation. The mean incline of DNA synthesis at 48 and 72 h post-infection was 148 and 197 %, respectively. Addition of neutralizing antibodies against VEGF completely abolished this effect. Supernatants from SMC cultures incubated with UV-inactivated virus induced a comparable effect. This virus-induced paracrine effect may represent a molecular mechanism for HCMV-induced pathogenesis, such as inflammatory vasculopathies, by inducing a proatherogenic phenotype in SMC.
BarleonB.,
SozzaniS.,
ZhouD.,
WeichH. A.,
MantovaniA.,
MarméD.1996; Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336–3343
BrowneE. P.,
WingB.,
ColemanD.,
ShenkT.2001; Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol 75:12319–12330[CrossRef]
ClaussM.,
GerlachM.,
GerlachH.7 other authors1990; Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535–1545[CrossRef]
CouffinhalT.,
KearneyM.,
WitzenbichlerB.,
ChenD.,
MuroharaT.,
LosordoD. W.,
SymesJ.,
IsnerJ. M.1997; Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 150:1673–1685
de BoerO. J.,
van der WalA. C.,
TeelingP.,
BeckerA. E.1999; Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?. Cardiovasc Res 41:443–449[CrossRef]
FinkenzellerG.,
SparacioA.,
TechnauA.,
MarméD.,
SiemeisterG.1997; Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15:669–676[CrossRef]
InoueM.,
ItohH.,
UedaM.13 other authors1998; Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98:2108–2116[CrossRef]
MichelD.,
PavićI.,
ZimmermannA.,
HauptE.,
WunderlichK.,
HeuschmidM.,
MertensT.1996; The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J Virol 70:6340–6347
MinisiniR.,
TuloneC.,
LüskeA.,
MichelD.,
MertensT.,
GierschikP.,
MoeppsB.2003; Constitutive inositol phosphate formation in cytomegalovirus-infected human fibroblasts is due to expression of the chemokine receptor homologue pUS28. J Virol 77:4489–4501[CrossRef]
MoultonK. S.,
VakiliK.,
ZurakowskiD.7 other authors2003; Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 100:4736–4741[CrossRef]
MurayamaT.,
OharaY.,
ObuchiM.,
KhabarK. S. A.,
HigashiH.,
MukaidaN.,
MatsushimaK.1997; Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF- κ B-binding sites of the interleukin-8 gene. J Virol 71:5692–5695
ReinhardtB.,
VaidaB.,
VoisardR.7 other authors2003; Human cytomegalovirus infection in human renal arteries in vitro. J Virol Methods 109:1–9[CrossRef]
SedmakD. D.,
KnightD. A.,
VookN. C.,
WaldmanJ. W.1994; Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 58:1379–1385
SpeirE.,
ModaliR.,
HuangE. S.,
LeonM. B.,
ShawlF.,
FinkelT.,
EpsteinS. E.1994; Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391–394[CrossRef]
SrivastavaR.,
CurtisM.,
HendricksonS.,
BurnsW. H.,
HosenpudJ. D.1999; Strain specific effects of cytomegalovirus on endothelial cells: implications for investigating the relationship between CMV and cardiac allograft vasculopathy. Transplantation 68:1568–1573[CrossRef]
ZhengM.,
DeshpandeS.,
LeeS.,
FerraraN.,
RouseB. T.2001; Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 75:9828–9835[CrossRef]
ZhouY. F.,
LeonM. B.,
WaclawiwM. A.,
PopmaJ. J.,
YuZ. X.,
FinkelT.,
EpsteinS. E.1996; Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335:624–630[CrossRef]
ZhuH.,
CongJ.-P.,
MamtoraG.,
GingerasT.,
ShenkT.1998; Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A 95:14470–14475[CrossRef]